Does Mounjaro Affect Your Taste Buds and Food Preferences?

What clinical evidence shows about tirzepatide and taste perception

The SURMOUNT-1 trial, published in the New England Journal of Medicine, randomised 2,539 adults over 72 weeks and captured a broad side-effect profile across all doses. Taste changes were not among the primary outcomes, but dysgeusia (the medical term for altered or distorted taste) appeared in the trial's full adverse-event data, more commonly at higher doses and around the time of each upward titration step. The effect was generally mild and transient.

What this tells us is that taste changes in tirzepatide users are real enough to show up in structured trial monitoring, but infrequent enough that they sit below the threshold most people would anticipate. The NHS medicines page for tirzepatide lists unusual taste as an uncommon side effect, meaning it occurs in roughly one to ten people per hundred. That is worth knowing before you start, not after.

One common misconception is that this represents permanent damage to taste receptor cells, and if you want a closer look at exactly what is and is not changing, our page on whether Mounjaro changes your taste buds works through the evidence in detail. The current evidence points to a central and hormonal mechanism rather than anything happening to the tongue itself, which matters because it frames the experience correctly: temporary and functional, not structural.

Why Mounjaro changes how food tastes and feels rewarding

Tirzepatide activates both GIP and GLP-1 receptors, two gut-hormone pathways involved in appetite regulation, blood glucose and the brain's response to eating. GLP-1 receptors are found not just in the gut and pancreas but in areas of the brain that process the reward value of food. When those pathways are modulated, the subjective experience of eating can shift in ways that go beyond simply feeling full sooner.

Some people find that foods they previously craved (particularly high-fat, very sweet or strongly flavoured items) suddenly seem less appealing or even slightly off-putting. Others notice a metallic or bitter aftertaste following meals, especially fatty ones. A smaller group report that previously enjoyable flavours taste muted or flat altogether. These are distinct experiences that share the same underlying route: the brain's valuation of food is being recalibrated alongside appetite and satiety.

For more detail on the broader sensory changes some people notice, our page on taste in the mouth on Mounjaro covers the specific presentations that patients ask about most. It is also worth knowing that some of the same mechanisms may ripple into other areas of physiology, our team has written about how Mounjaro may interact with HRT and its potential effect on oral contraceptive absorption, both of which come up regularly in consultations.

How long do taste changes last, and does anything help?

In most cases, taste disturbances appear close to a dose increase and ease off over the following two to four weeks as the body adjusts. They tend not to worsen throughout treatment; if anything, they become less noticeable once you reach and settle on a maintenance dose. Staying well hydrated helps, since dehydration amplifies taste distortion. Eating slowly and avoiding very strong flavours during the adjustment window is another practical step most people find useful.

The taste changes are not a reason to stop treatment unless they are significantly affecting nutrition or quality of life. If you are finding it difficult to eat adequate protein or are avoiding whole food groups because of taste aversion, that is a conversation for your prescriber. It is also worth separating taste changes from nausea, the two can coexist and reinforce each other, but they have different timelines and respond to different adjustments. For a fuller picture of what Mounjaro is and how it works, the Mounjaro overview and our broader tirzepatide information page give useful context alongside the clinical evidence.

If you are currently on tirzepatide and a side effect feels unusual or persistent, the MHRA's Yellow Card scheme allows patients to report their experiences directly, and those reports genuinely feed into post-market safety monitoring for medicines like this one.

If you are still considering whether tirzepatide is the right option for your situation, you can check your eligibility with our prescribers through a free consultation, reviewed the same day by a GPhC-registered clinician. Our FAQs page covers many of the practical questions people have before starting.